Blood-brain barrier properties of human immunodeficiency virus antiretrovirals
J Pharm Sci
.
1999 Oct;88(10):950-4.
doi: 10.1021/js990174i.
Author
M Yazdanian
1
Affiliation
1
Department of Pharmaceutics, Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877, USA. myazdani@rdg.boehringer-ingelheim.com
PMID:
10514337
DOI:
10.1021/js990174i
No abstract available
Publication types
Review
MeSH terms
Animals
Anti-HIV Agents / pharmacokinetics*
Blood-Brain Barrier / drug effects
Blood-Brain Barrier / physiology*
HIV Infections / metabolism
Humans
Substances
Anti-HIV Agents